Skip to content
← Full study record

NCT01165996 · MORE INFO

Limitations, agreements, and source contact

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome · Source last updated 2019-03-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
point Of Contact
email
saunthy@ccf.org
organization
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
phone
216-444-8170
title
Yogen Saunthararajah, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
point Of Contact
email
saunthy@ccf.org
organization
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
phone
216-444-8170
title
Yogen Saunthararajah, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice